Cargando…
Breast cancer: further metabolic-endocrine risk markers?
There is evidence that increased oestrogen receptor (ER) expression in normal mammary epithelium may be a risk marker for the development of breast cancer. Insulin-like growth factor 1 (IGF1) is a potent inducer of mitosis and has been shown to synergize with oestrogen in stimulating the growth of h...
Autor principal: | Stoll, B. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228209/ https://www.ncbi.nlm.nih.gov/pubmed/9413957 |
Ejemplares similares
-
Predictive markers of endocrine response in breast cancer
por: Mosly, Duniya, et al.
Publicado: (2018) -
Editorial: Further advances in understanding the endocrine cancer microenvironment
por: Coperchini, Francesca, et al.
Publicado: (2022) -
4-hydroxyandrostenedione--further clinical and extended endocrine observations.
por: Pickles, T., et al.
Publicado: (1990) -
S100β as a serum marker in endocrine resistant breast cancer
por: Charmsaz, Sara, et al.
Publicado: (2017) -
Metabolic Adaptations in an Endocrine-Related Breast Cancer Mouse Model Unveil Potential Markers of Tumor Response to Hormonal Therapy
por: Araújo, Rita, et al.
Publicado: (2022)